In sorafenib-resistant HCC, nuclear factor E2-related factor 2 (NRF-2) promoted expression of PD-L1 by suppressing microRNA-1 (miR-1) which was a tumor-inhibitory microRNA (31). Here, CD274 is linked to hepatocellular carcinoma.